Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)
Completed
Conditions studied: Parkinson Disease
In brief
The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.
Key facts
- Study ID
- NCT00617019
- Run by
- Boehringer Ingelheim
- People needed
- 3234
- Starts
- 2006-09-01
- Last updated by the study team
- 2013-11-13
Who can join
Age: 30 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Observation Criteria:
- Male or female outpatients, aged 30 to 75 years of age, with idiopathic PD. Patients must be selected on the basis of a prospective recruitment plan documented at the site, with the objective of obtaining an unbiased representative sample.
- Patients must have been treated with anti-parkinson medication for a period of one year or greater and demonstrated a treatment response, in the opinion of the Investigator.
- Patients must be willing and able to comply with study procedures. Patients must be willing and able to give meaningful, written informed consent. This must be completed prior to beginning any study procedures, in accordance with GCP and local legislation.
Where it is running
- 248.619.01034 Neurological Physicians of Arizona — Gilbert, Arizona, United States
- 248.619.01007 Mayo Clinic - Scottsdale — Scottsdale, Arizona, United States
- 248.619.01025 Sun Health Research Institute — Sun City, Arizona, United States
- 248.619.01018 Margolin Brain Institute — Fresno, California, United States
- 248.619.01031 Pacific Neuroscience Medical Group, Inc. — Oxnard, California, United States
- 248.619.01016 San Francisco VA PD Research, Education, & Clinical Center — San Francisco, California, United States
- 248.619.01023 The Parkinson's Institute — Sunnyvale, California, United States
- 248.619.01021 Boehringer Ingelheim Investigational Site — Englewood, Colorado, United States
- 248.619.01027 Associated Neurologists, P.C. — Danbury, Connecticut, United States
- 248.619.01013 Molecular NeuroImaging — New Haven, Connecticut, United States
- 248.619.01020 Parkinson's Disease and Movement Disorders of Boca Raton — Boca Raton, Florida, United States
- 248.619.01009 University of Florida — Gainesville, Florida, United States
- 248.619.01035 Emory University — Atlanta, Georgia, United States
- 248.619.01006 Medical College of Georgia — Augusta, Georgia, United States
- 248.619.01014 Northwestern University — Chicago, Illinois, United States
- 248.619.01001 The University of Kansas Medical Center — Kansas City, Kansas, United States
- 248.619.01015 John Hopkins Hospital — Baltimore, Maryland, United States
- 248.619.01029 Clinical Neuroscience Center — Southfield, Michigan, United States
- 248.619.01022 University of Minnesota — Minneapolis, Minnesota, United States
- 248.619.01008 Robert Wood Johnson Medical School — Piscataway, New Jersey, United States
- 248.619.01030 Parkinson's Disease and Movement Disorders Center — Albany, New York, United States
- 248.619.01036 Parkinson's Disease and Mov. Disorders Center of Long Island — Commack, New York, United States
- 248.619.01017 Weill Cornell medical College — New York, New York, United States
- 248.619.01003 Duke University Medical Center — Durham, North Carolina, United States
- 248.619.01028 The Cleveland Clinic Foundation — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.